Ken Mulvany, Chairman of BenevolentAI will be joining a great line-up of scientists, engineers, entrepreneurs and visionaries at Codex to discuss the future of healthcare.
Serial entrepreneur, investor and healthcare and technology veteran with more than 20 years of business leadership experience. He is currently a director of BenevolentAI, a technology company he founded, which is developing and using Artificial Intelligence to change the way knowledge is created and applied in Life Sciences. He was previously CEO of Proximagen, a UK-based biotech company committed to delivering novel drugs and innovative new treatments for central nervous system (CNS) disorders
Can a machine cure disease?
AI has the potential to positively and dramatically change our world. In healthcare, AI advances are being made in diagnosis and better care but is the technology capable of curing disease?